Clinical Trials on Cardiomyopathies, Secondary

Total 2732 results

HaEmek Medical Center, Israel

Completed

The Impact of Infectious Disease on QT Segment

Pneumonia | Sepsis | Cardiomyopathy, Secondary

Israel
Medical University of Warsaw

Recruiting

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. (IMPROVE-MC)

Heart Failure | Myocarditis | Immunosuppression | Cardiomyopathies, Secondary | Endomyocardial Biopsy

Poland
Oliver Strohm
Bayer

Completed

Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR

Cardiomyopathy, Dilated | Cardiomyopathies, Secondary

Canada
Rush University Medical Center

Completed

The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor

Breast Cancer | Cardiomyopathies, Secondary | Doxorubicin Adverse Reaction

United States
Saint Francis Care
Medtronic

Completed

A Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations (PropR)

Ischemic and Nonischemic Cardiomyopathy, With Primary and Secondary Implant Indications

United States
University Hospital, Antwerp

Not yet recruiting

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy

Heart Failure | Amyloidosis | Amyloidosis Cardiac | Cardiomyopathies, Secondary | Amyloid Polyneuropathy | Cardiomyopathy Non-Dilated

Belgium
The Second Hospital of Nanjing Medical University

Recruiting

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism;Parathyroidectomy

China
Chang Gung Memorial Hospital

Completed

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Secondary Hyperparathyroidism Due to Renal Causes

Taiwan
Fundación Senefro
AbbVie; Effice Servicios Para la Investigacion S.L.

Completed

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (PARIDOINAL)

Secondary Hyperparathyroidism Due to Renal Causes

Spain
Phramongkutklao College of Medicine and Hospital

Completed

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Shanghai Zhongshan Hospital

Unknown

Preemptive and Precise Intervention for CKD-SHPT

Hyperparathyroidism; Secondary, Renal
China-Japan Friendship Hospital

Recruiting

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Hospital General Ajusco Medio

Completed

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Mexico
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kumamoto University

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Federal University of Pelotas

Active, not recruiting

Caries Cognition and Identification in Adults (CaCIA)

Secondary Caries

Brazil
Jazz Pharmaceuticals

Approved for marketing

EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML (401)

Secondary AML

United States
Abbott

Completed

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

Secondary Hyperparathyroidism | Dialysis

Mexico
St. Jude Children's Research Hospital

Recruiting

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

Childhood Cancer | Cardiomyopathy, Primary

United States
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Japan
Deltanoid Pharmaceuticals

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Penang Hospital, Malaysia
Ministry of Health, Malaysia

Unknown

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

Secondary Hyperparathyroidism

Malaysia
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc.

Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level (CUPID)

Secondary Hyperparathyroidism

Korea, Republic of
Cairo University

Unknown

Reliability of Secondary Caries Detection Around Composite Restoration Using Light Induced Fluorescence

Secondary Caries

Egypt
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Papageorgiou General Hospital

Terminated

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Secondary Hyperparathyroidism

Greece
Abbott
Statistika Consultoria Ltda

Terminated

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Secondary Hyperparathyroidism | Dialysis

Brazil
Vestre Viken Hospital Trust
Oslo University Hospital; The Hospital of Vestfold; Kalmar County Hospital

Completed

The NOR-COR Study for Coronary Prevention

Secondary Coronary Prevention

Norway
Mersin University

Completed

Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism | Myocardial Dysfunction

Turkey
Min-Sheng General Hospital
Taipei Medical University; Taipei Medical University Shuang Ho Hospital; National... and other collaborators

Completed

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Hyperparathyroidism; Secondary, Renal

Taiwan
Wenhu Liu

Unknown

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Secondary Hyperparathyroidism | Maintenance Hemodialysis

China
Beijing Friendship Hospital

Unknown

the Study on Prognostic for Hemodialysis Patients

Secondary Hyperparathyroidism

China
Josep M Cruzado

Completed

Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation

Secondary Hyperparathyroidism

Spain
Mario Negri Institute for Pharmacological Research

Completed

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)

Renal Transplant | Secondary Hyperparathyroidism

Italy
Fifth Affiliated Hospital, Sun Yat-Sen University

Completed

Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

Secondary Hyperparathyroidism | Parathyroid Gland Disease

China
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

Hyperparathyroidism; Secondary, Renal

China
University of Maryland, Baltimore

Completed

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism (1hydroxylase)

Secondary Hyperparathyroidism

United States
Papageorgiou General Hospital

Completed

Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Imperial College London
University College, London

Recruiting

Screening Women for Functional Hypothalamic Amenorrhea (FHA)

Amenorrhea Secondary

United Kingdom
Nantes University Hospital
University Hospital, Angers; University Hospital, Brest; University Hospital,...

Not yet recruiting

Issue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy (CharACTPET-MR)

Arrhythmogenic Cardiomyopathies

France
Cairo University

Recruiting

Validity of Fluorescence-Based Devices Versus Visual-Tactile Method in Detection of Secondary Caries Around Resin Composite Restorations: Invivo Diagnostic Accuracy Study

Secondary Caries Around Resin Composite Restorations

Egypt
TherapeuticsMD

Terminated

A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea (SPRY)

Secondary Amenorrhea

United States

Clinical Trials on Cardiomyopathies, Secondary

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations